Search
for
Sort by
Research 271–300 of 332
- Comparison of clinical trials with finasteride and dutasteride.
- Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia
- The association of medications and supplements with human male reproductive health: a systematic review
- Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
- The Benefits of Dual Inhibition of 5α Reductase
- Why Odds Ratios Can Be Tricky Statistics
- Evaluation of men on finasteride.
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Physical Treatments and Therapies for Androgenetic Alopecia
- Abstracts from the current global literature: Finasteride and sexual dysfunction
- Finasteride as a Neo-Adjuvant Treatment for TURPLiterature Review
- 5alpha-reductase: history and clinical importance.
- Treatment of chronic prostatitis/chronic pelvic pain syndrome
- The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Hair Restoration in Androgenetic Alopecia: Looking Beyond Minoxidil, Finasteride and Hair Transplantation
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia
- Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
- Letter to the Editor on “COVID-19 Infection in Men on Testosterone Replacement Therapy”
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Risk of New-Onset Postoperative Depression After Holmium Laser Enucleation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Nationwide Retrospective Cohort Study
- DUTASTERIDE AS AN EFFECTIVE TREATMENT IN ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san
- EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA